Roivant Sciences Ltd.
ROIV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001635088
In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 9 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Members of Congress who traded ROIV
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 4
- Filings
- 2
- Members
- 1
- Buys / sells
- 2 / 2
- Estimated volume
- $32.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Lisa C. McClainRepublican · House · MI | 4 | 2 / 2 | $32.0K | Oct 31, 2025 | Nov 21, 2025 |
Trades
Every reported trade in Roivant Sciences Ltd., newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Lisa C. McClainRepublican · House · MI | ROIVRoivant Sciences Ltd. - Common Shares | Buy | Spouse | Jun 17, 2025 | Aug 13, 2025 | 57 daysLate | $1K-$15K | Filing |
| Lisa C. McClainRepublican · House · MI | ROIVRoivant Sciences Ltd. - Common Shares | Sell | Spouse | Oct 30, 2025 | Nov 21, 2025 | 22 days | $1K-$15K | Filing |
| Lisa C. McClainRepublican · House · MI | ROIVRoivant Sciences Ltd. - Common Shares | Buy | Spouse | Oct 30, 2025 | Nov 21, 2025 | 22 days | $1K-$15K | Filing |
| Lisa C. McClainRepublican · House · MI | ROIVRoivant Sciences Ltd. - Common Shares | Sell | Spouse | Oct 31, 2025 | Nov 21, 2025 | 21 days | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.